课题基金 / 基金详情

NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION

NOVEL ANTIHYPERTENSIVES: RATIONAL DESIGN AND EVALUATION
新型抗高血压药:合理设计和评估
批准号:
3339576
负责人:
SHELDON W MAY
金额:
$24.86万
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-01-01 至 1994-06-30

项目摘要

项目成果

SHELDON W MAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hypertension is a causative factor in the genesis of many cardiovascular diseases, and is thus the focus of much current research. We are investigating and evaluating -- at the cellular, molecular enzymological and whole animal levels -- novel but structurally simple compounds of our own design which have the potential of acting as antihypertensive agents. Our compounds are designed so that in many cases they can act as pro-drugs or suicide substrates which we expect to affect principally the peripheral nervous system, although in some cases central effects may also be present. A variety of experimental approaches, ranging from bioassays to subcellular fraction experiments to enzymatic studies, are being employed. It is hoped that our results will establish the basis for design of new classes of clinically useful compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEUROPEPTIDES--APPROACHES TO ALPHA-AMIDATION EFFECTORS
  • 批准号:
    3298182
  • 项目类别:
  • 资助金额:
    $21.15万
  • 财政年份:
    1992
  • 负责人:
    SHELDON W MAY
  • 依托单位:
NEUROPEPTIDES--APPROACH TO AMIDATION EFFECTORS
  • 批准号:
    2022242
  • 项目类别:
  • 资助金额:
    $24.39万
  • 财政年份:
    1992
  • 负责人:
    SHELDON W MAY
  • 依托单位:
NEUROPEPTIDES--APPROACH TO AMIDATION EFFECTORS
  • 批准号:
    2684894
  • 项目类别:
  • 资助金额:
    $20.79万
  • 财政年份:
    1992
  • 负责人:
    SHELDON W MAY
  • 依托单位:
NEUROPEPTIDES--APPROACHES TO ALPHA-AMIDATION EFFECTORS
  • 批准号:
    3298181
  • 项目类别:
  • 资助金额:
    $22.66万
  • 财政年份:
    1992
  • 负责人:
    SHELDON W MAY
  • 依托单位:
海外基金